Stoke Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Stoke Therapeutics, Inc. (STOK) reported Increase (Decrease) in Prepaid Expense and Other Assets of $7.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-03
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $3.91M, a 56.17% decline year-over-year.
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $3.59M, a 191.71% increase year-over-year.
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$220.00K, a 112.64% decline year-over-year.
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$9.39M.
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $545.00K, a 69.48% decline from fiscal 2024.
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.79M.
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$529.00K, a 110.21% decline from fiscal 2022.
- Stoke Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $5.18M, a 81.80% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $7.50M 10-Q · filed 2026-08-03 | $7.28M derived: sum of 3 quarters · filed 2026-08-03 | -$2.11M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $3.59M 10-Q · filed 2026-05-07 | $3.37M derived: sum of 2 quarters · filed 2026-05-07 | -$6.03M derived: sum of 3 quarters · filed 2026-05-07 | $2.90M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$9.61M derived: sum of 2 quarters · filed 2026-03-16 | -$685.00K derived: sum of 3 quarters · filed 2026-08-03 | $545.00K 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | -$9.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$465.00K derived: sum of 2 quarters · filed 2026-08-03 | $765.00K 10-Q · filed 2025-11-04 | $2.51M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $8.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $10.16M 10-Q · filed 2026-08-03 | $6.41M 10-Q · filed 2025-08-12 | $11.90M derived: sum of 3 quarters · filed 2026-08-03 | $10.95M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | $1.23M 10-Q · filed 2026-05-07 | $2.56M 10-Q · filed 2025-05-13 | $2.97M derived: sum of 2 quarters · filed 2026-05-07 | $2.02M derived: sum of 3 quarters · filed 2026-05-07 | $2.67M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $793.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.44M derived: sum of 3 quarters · filed 2026-03-16 | $1.79M 10-K · filed 2026-03-16 | $1.84M 10-K · filed 2025-03-18 | |||
| 2024-09-30 | -$948.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$304.00K derived: sum of 2 quarters · filed 2025-11-04 | $45.00K 10-Q · filed 2025-11-04 | $393.00K 10-Q · filed 2024-11-05 | -$1.31M derived: sum of 4 quarters · filed 2025-11-04 | |||
| 2024-06-30 | $644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $993.00K 10-Q · filed 2025-08-12 | -$360.00K derived: sum of 3 quarters · filed 2025-08-12 | $154.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $349.00K 10-Q · filed 2025-05-13 | -$1.00M derived: sum of 2 quarters · filed 2025-05-13 | -$490.00K derived: sum of 3 quarters · filed 2025-05-13 | -$2.27M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$839.00K derived: sum of 2 quarters · filed 2025-03-18 | -$2.62M derived: sum of 3 quarters · filed 2025-03-18 | -$529.00K 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | $514.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$1.26M derived: sum of 2 quarters · filed 2024-11-05 | $824.00K 10-Q · filed 2024-11-05 | $2.35M derived: sum of 4 quarters · filed 2024-11-05 | ||||
| 2023-06-30 | -$1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $310.00K 10-Q · filed 2024-08-07 | $1.84M derived: sum of 3 quarters · filed 2024-08-07 | $1.26M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $2.09M 10-Q · filed 2024-05-06 | $3.62M derived: sum of 2 quarters · filed 2024-05-06 | $3.04M derived: sum of 3 quarters · filed 2024-05-06 | $4.01M derived: sum of 4 quarters · filed 2024-05-06 | ||||
| 2022-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $947.00K derived: sum of 2 quarters · filed 2024-03-25 | $1.92M derived: sum of 3 quarters · filed 2024-03-25 | $5.18M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | -$581.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $390.00K derived: sum of 2 quarters · filed 2023-11-07 | $3.65M 10-Q · filed 2023-11-07 | $4.43M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $971.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $4.24M 10-Q · filed 2023-08-07 | $5.01M derived: sum of 3 quarters · filed 2023-08-07 | $4.79M derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | $3.27M 10-Q · filed 2023-05-04 | $4.04M derived: sum of 2 quarters · filed 2023-05-04 | $3.81M derived: sum of 3 quarters · filed 2023-05-04 | $5.04M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $778.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $550.00K derived: sum of 2 quarters · filed 2023-03-06 | $1.77M derived: sum of 3 quarters · filed 2023-03-06 | $2.85M 10-K · filed 2023-03-06 | ||||
| 2021-09-30 | -$228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $995.00K derived: sum of 2 quarters · filed 2022-11-14 | $2.07M 10-Q · filed 2022-11-14 | $4.90M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.30M 10-Q · filed 2022-08-08 | $5.12M derived: sum of 3 quarters · filed 2022-08-08 | $5.20M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $1.08M 10-Q · filed 2022-05-10 | $3.90M derived: sum of 2 quarters · filed 2022-05-10 | $3.98M derived: sum of 3 quarters · filed 2022-05-10 | $3.03M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.90M derived: sum of 2 quarters · filed 2022-03-10 | $1.95M derived: sum of 3 quarters · filed 2022-03-10 | $2.88M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$869.00K derived: sum of 2 quarters · filed 2021-11-08 | $55.00K 10-Q · filed 2021-11-08 | -$808.00K derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | -$949.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$25.00K 10-Q · filed 2021-08-10 | -$888.00K derived: sum of 3 quarters · filed 2021-08-10 | $978.00K derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $924.00K 10-Q · filed 2021-05-10 | $61.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.93M derived: sum of 3 quarters · filed 2021-05-10 | $2.15M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | -$863.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $1.00M derived: sum of 2 quarters · filed 2021-03-09 | $1.23M derived: sum of 3 quarters · filed 2021-03-09 | $2.02M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $2.09M derived: sum of 2 quarters · filed 2020-11-12 | $2.89M 10-Q · filed 2020-11-12 | $3.21M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.02M 10-Q · filed 2020-08-10 | $1.35M derived: sum of 3 quarters · filed 2020-08-10 | $1.61M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $796.00K 10-Q · filed 2020-05-15 | $1.12M derived: sum of 2 quarters · filed 2020-05-15 | $1.39M derived: sum of 3 quarters · filed 2020-05-15 | |||||
| 2018-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $590.00K derived: sum of 2 quarters · filed 2020-03-23 | $632.00K 10-K · filed 2020-03-23 | |||||
| 2018-09-30 | $263.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $305.00K 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | $42.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |